FNWFX
Price
$106.02
Change
-$1.96 (-1.82%)
Updated
Jul 2 closing price
Net Assets
90.88B
WAESX
Price
$20.23
Change
+$0.01 (+0.05%)
Updated
Jul 2 closing price
Net Assets
172.49M
Interact to see
Advertisement

FNWFX vs WAESX

FNWFX vs WAESX Comparison Chart in %
View a ticker or compare two or three
VS
FNWFX vs. WAESX commentary
Jul 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FNWFX is a Buy and WAESX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FNWFX has more cash in the bank: 90.9B vs. WAESX (172M). FNWFX pays higher dividends than WAESX: FNWFX (1.24) vs WAESX (0.00). FNWFX was incepted earlier than WAESX: FNWFX (9 years) vs WAESX (14 years). WAESX (1.37) is less costly to investors than FNWFX (0.57). FNWFX is a more actively managed with annual turnover of: 46.00 vs. WAESX (28.00). WAESX has a lower initial minimum investment than FNWFX: WAESX (2000) vs FNWFX (1000000). FNWFX annual gain was more profitable for investors over the last year : 20.57 vs. WAESX (12.64). FNWFX return over 5 years is better than : 15.20 vs. WAESX (-3.30).
FNWFXWAESXFNWFX / WAESX
Total Expense Ratio0.571.3742%
Annual Report Gross Expense Ratio0.571.3742%
Fund Existence9 years14 years-
Gain YTD13.71911.032124%
Front LoadN/AN/A-
Min. Initial Investment1000000200050,000%
Min. Initial Investment IRAN/AN/A-
Net Assets90.9B172M52,849%
Annual Yield % from dividends1.240.00-
Returns for 1 year20.5712.64163%
Returns for 3 years48.6330.18161%
Returns for 5 years15.20-3.30-461%
Returns for 10 yearsN/A126.54-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RAGHX29.890.83
+2.86%
Virtus KAR Health Sciences A
MINHX46.390.71
+1.55%
MFS International Intrinsic Equity R4
JORRX20.590.13
+0.64%
Janus Henderson Global Select R
TWAIX14.270.01
+0.07%
Thrivent International Equity S
CMIDX21.00-0.22
-1.04%
Congress Mid Cap Growth Retail